170 related articles for article (PubMed ID: 21482080)
41. Methicillin resistant Staphylococcus aureus: carriage rates and characterization of students in a Texas university.
Rohde RE; Denham R; Brannon A
Clin Lab Sci; 2009; 22(3):176-84. PubMed ID: 19827412
[TBL] [Abstract][Full Text] [Related]
42. Case-control study to identify factors associated with mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia.
Marchaim D; Kaye KS; Fowler VG; Anderson DJ; Chawla V; Golan Y; Karchmer AW; Carmeli Y
Clin Microbiol Infect; 2010 Jun; 16(6):747-52. PubMed ID: 19723135
[TBL] [Abstract][Full Text] [Related]
43. [Evaluation of pharmacodynamic target attainment with vancomycin treatment of bacteremia due to Staphylococcus aureus methicillin resistant].
Lepe JA; Gil-Navarro MV; Santos-Rubio MD; Bautista J; Aznar J
Rev Esp Quimioter; 2010 Mar; 23(1):43-7. PubMed ID: 20232023
[TBL] [Abstract][Full Text] [Related]
44. [Methicillin-resistant Staphylococcus aureus bacteremia. Predictor factors for an isolate with a vancomycin minimal inhibitory concentration > or =2 mg/l].
Ortega M; Marco F; Soriano A; Almela M; Martínez JA; Muñoz A; Mensa J
Rev Esp Quimioter; 2008 Jun; 21(2):93-8. PubMed ID: 18509768
[TBL] [Abstract][Full Text] [Related]
45. Adult methicillin-resistant Staphylococcus aureus bacteremia in Taiwan: clinical significance of non-multi-resistant antibiogram and Panton-Valentine leukocidin gene.
Wang JL; Wang JT; Chen SY; Hsueh PR; Kung HC; Chen YC; Chang SC
Diagn Microbiol Infect Dis; 2007 Dec; 59(4):365-71. PubMed ID: 17878063
[TBL] [Abstract][Full Text] [Related]
46. Methicillin-resistant Staphylococcus aureus resistance to non-beta-lactam antimicrobials in the United States from 1996 to 2008.
Bordon J; Master RN; Clark RB; Duvvuri P; Karlowsky JA; Ayesu K; Klotchko A; Kapoor R; Ramirez J
Diagn Microbiol Infect Dis; 2010 Aug; 67(4):395-8. PubMed ID: 20638612
[TBL] [Abstract][Full Text] [Related]
47. Methicillin resistant Staphylococcus aureus versus methicillin sensitive Staphylococcus aureus adult haematogenous septic arthritis.
Al-Nammari SS; Bobak P; Venkatesh R
Arch Orthop Trauma Surg; 2007 Sep; 127(7):537-42. PubMed ID: 17260151
[TBL] [Abstract][Full Text] [Related]
48. Methicillin-resistant Staphylococcus aureus bacteremia: epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK.
Lewis T; Chaudhry R; Nightingale P; Lambert P; Das I
Int J Infect Dis; 2011 Feb; 15(2):e131-5. PubMed ID: 21134776
[TBL] [Abstract][Full Text] [Related]
49. Risk factors associated with methicillin-resistant Staphylococcus aureus infection in patients admitted to the ED.
Viallon A; Marjollet O; Berthelot P; Carricajo A; Guyomarc'h S; Robert F; Zeni F; Bertrand JC
Am J Emerg Med; 2007 Oct; 25(8):880-6. PubMed ID: 17920971
[TBL] [Abstract][Full Text] [Related]
50. Comparison of the clinical features, bacterial genotypes and outcomes of patients with bacteraemia due to heteroresistant vancomycin-intermediate Staphylococcus aureus and vancomycin-susceptible S. aureus.
Park KH; Kim ES; Kim HS; Park SJ; Bang KM; Park HJ; Park SY; Moon SM; Chong YP; Kim SH; Lee SO; Choi SH; Jeong JY; Kim MN; Woo JH; Kim YS
J Antimicrob Chemother; 2012 Aug; 67(8):1843-9. PubMed ID: 22535621
[TBL] [Abstract][Full Text] [Related]
51. Trends in sources of meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia: data from the national mandatory surveillance of MRSA bacteraemia in England, 2006-2009.
Wilson J; Guy R; Elgohari S; Sheridan E; Davies J; Lamagni T; Pearson A
J Hosp Infect; 2011 Nov; 79(3):211-7. PubMed ID: 21764174
[TBL] [Abstract][Full Text] [Related]
52. Activity of ACHN-490 against meticillin-resistant Staphylococcus aureus (MRSA) isolates from patients in US hospitals.
Tenover FC; Tickler I; Armstrong ES; Kubo A; Lopez S; Persing DH; Miller GH
Int J Antimicrob Agents; 2011 Oct; 38(4):352-4. PubMed ID: 21820877
[TBL] [Abstract][Full Text] [Related]
53. Increased mortality among elderly patients with meticillin-resistant Staphylococcus aureus bacteraemia.
Tacconelli E; Pop-Vicas AE; D'Agata EM
J Hosp Infect; 2006 Nov; 64(3):251-6. PubMed ID: 16978733
[TBL] [Abstract][Full Text] [Related]
54. Is methicillin-resistant Staphylococcus aureus more virulent than methicillin-susceptible S. aureus? A comparative cohort study of British patients with nosocomial infection and bacteremia.
Melzer M; Eykyn SJ; Gransden WR; Chinn S
Clin Infect Dis; 2003 Dec; 37(11):1453-60. PubMed ID: 14614667
[TBL] [Abstract][Full Text] [Related]
55. Mortality in patients with meticillin-resistant Staphylococcus aureus bacteraemia, England 2004-2005.
Lamagni TL; Potz N; Powell D; Pebody R; Wilson J; Duckworth G
J Hosp Infect; 2011 Jan; 77(1):16-20. PubMed ID: 21030112
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of dalbavancin, tigecycline, minocycline, tetracycline, teicoplanin and vancomycin against community-associated and multidrug-resistant hospital-associated meticillin-resistant Staphylococcus aureus.
Huang V; Cheung CM; Kaatz GW; Rybak MJ
Int J Antimicrob Agents; 2010 Jan; 35(1):25-9. PubMed ID: 19900792
[TBL] [Abstract][Full Text] [Related]
57. Prevalence of clinical meticillin-resistant Staphylococcus aureus (MRSA) with high-level mupirocin resistance in Shanghai and Wenzhou, China.
Liu QZ; Wu Q; Zhang YB; Liu MN; Hu FP; Xu XG; Zhu DM; Ni YX
Int J Antimicrob Agents; 2010 Feb; 35(2):114-8. PubMed ID: 19939636
[TBL] [Abstract][Full Text] [Related]
58. Activity of dalbavancin, alone and in combination with rifampicin, against meticillin-resistant Staphylococcus aureus in a foreign-body infection model.
Baldoni D; Furustrand Tafin U; Aeppli S; Angevaare E; Oliva A; Haschke M; Zimmerli W; Trampuz A
Int J Antimicrob Agents; 2013 Sep; 42(3):220-5. PubMed ID: 23880168
[TBL] [Abstract][Full Text] [Related]
59. Antimicrobial susceptibility of Staphylococcus aureus and characterization of methicillin-resistant Staphylococcus aureus isolated from bovine mastitis in Korea.
Nam HM; Lee AL; Jung SC; Kim MN; Jang GC; Wee SH; Lim SK
Foodborne Pathog Dis; 2011 Feb; 8(2):231-8. PubMed ID: 21034263
[TBL] [Abstract][Full Text] [Related]
60. Determination of the mutant selection window for clindamycin, doxycycline, linezolid, moxifloxacin and trimethoprim/sulfamethoxazole against community-associated meticillin-resistant Staphylococcus aureus (MRSA).
Allen GP; Deshpande LM
Int J Antimicrob Agents; 2010 Jan; 35(1):45-9. PubMed ID: 19910164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
